This review article reports on the new field of stem cell therapy and tissue engineering and
its potential on the management of congenital heart disease. To date, stem cell therapy has …

Although the important role of fibroblast growth factor (FGF) 23 on cardiac remodeling has
been suggested in advanced chronic kidney disease (CKD), little is known about serum (s) …

Aortic valve calcification is a common clinical disease, caused by valve interstitial cells
(VICs), which initiate the thickening and then calcification of valve leaflets. Classical valve …

Osteogenic endothelial progenitor cells (EPCs) contribute to impaired endothelial repair and
promote coronary artery disease (CAD) and vascular calcification. Immature EPCs …

Background A growing body of evidence links coronary artery atherosclerosis and
calcification to osteoporosis in women. The endothelium plays a critical role in maintaining …

As the world's older population grows, the disease burden of atherosclerosis is rapidly
increasing, causing significant morbidity and mortality worldwide. Despite recent …

Background. Currently, the search for the bioactive molecules capable of promoting
formation of the vascular tissue is still ongoing. We have previously demonstrated that …

Lack of growth potential of available grafts represents a bottleneck in the correction of
congenital heart defects. Here we used a swine small intestinal submucosa (SIS) graft …

Background Herniated discs may exhibit calcification, and calcified discs may complicate
surgical treatment. However, the osteogenic potential and expression of osteogenic markers …

Circulating osteogenic progenitor (COP) cells are considered as surrogates of the
mesenchymal repository in the body. In this study, we hypothesized that COP cells decrease …